【摘 要】
:
Rationale: We designed this study to integrate in vivo assessment of left ventricular (LV) morphology and function and in vitro assays of isolated adult cardiac fibroblasts to determine whether blocka
【机 构】
:
Department of Pharmacology University of Mississippi School of Pharmacy USA
【出 处】
:
BITs 1rd Annual World Cancer Congress of Cardiology-2009(200
论文部分内容阅读
Rationale: We designed this study to integrate in vivo assessment of left ventricular (LV) morphology and function and in vitro assays of isolated adult cardiac fibroblasts to determine whether blockade of either PAR-2 using the PAR-inactivating peptide, FSRLLY, or the Cox-2 selective inhibitor, Nimesulide (Nime), will prevent changes in LV structure and function secondary to an aortocaval fistula (ACF) volume overload.Further, we hypothesize that binding of tryptase to the PAR-2 receptor on cardiac fibroblasts will lead to increased expression of Cox-2 and subsequent formation of the arachodonic acid metabolite 15-d-Prostaglandin J2 (15-d-PGJ2).Methods/Results: LV volume and function were assessed by echocardiography and pressure/volume catheter at 7 and 14 days post surgery in four groups (n≥6 per group): 1) sham-operated (Sham); 2) untreated ACF; 3) ACF + Nime (10 mg/kg/day); and 4) ACF + PAR-2 antagonist (FSRLLY, 10μg/kg/day).The effects of tryptase (100mU) and co-incubation with FSRLLY (10-6M) on proliferation, hydroxyproline concentration, 15-d-PGJ2 formation and PAR-2/COX-2 expression were investigated in fibroblasts isolated from 9 wk old SD rats.The significant increase seen cardiac output, stroke volume, end diastolic volume, end systolic volume and end diastolic pressure in the untreated ACF group was significantly attenuated by Nimesulide treatment.In isolated adult cardiac fibroblasts tryptase induced a significant increase in fibroproliferation, hydroxyproline, 15-d-PGJ2 formation and PAR-2 expression which were markedly attenuated by FSRLLY.These results indicate that Cox-2 inhibition was able to prevent the initial changes in LV chamber dilatation and tryptase-induced changes in cardiac fibroblast phenotype utilizes a PAR-2 dependent mechanism.
其他文献
The presentation follows the most recent classification of pulmonary hypertension (2008 4th World Symposium on PH, Dana Point, California) and discusses a specific category of pulmonary vasculopathy,
Pulmonary hypertension (PH) leads to progressive increase of pulmonary vascular resistance, heart failure and death.Pulmonary arterial hypertension (PAH) is a subset of PH affecting small pulmonary ar
Background: Matrix metalloproteinases (MMPs) are directly implicated in degradation of extracellular matrix.Multiple studies have shown that MMPs and their inhibitors are involved in various pathologi
Objective: Clinical observations and some preliminary studies have suggested that an inadequate psychological adjustment to heart transplantation may increase the risk of poor clinical outcome.Yet, th
Vascular smooth muscle cells (VSMC) proliferation plays a critical role in the development and progression of several vasculopathies.Adenosine monophosphate-activated protein kinase α (AMPKα) is repor
The production of 20-hydroxyeicosatetraenoic acid (20-HETE) is increased during ischemia-reperfusion, and inhibition of 20-HETE production has been shown to reduce infarct size caused by ischemia.This
Objective :Rheumatic fever (RF) and its sequel, Rheumatic Heart Disease (RHD) is a disease of significant medical and public health concern.Valvular heart disease (VHD) is the term given to any diseas
The normal left ventricle (LV) is a structurally inhomogeneous pump according to features such as its geometry, the intricacy of the muscular fiber architecture, regional differences in wall thickness
Evidence shows that females have lower TNF α levels and lower incidences of heart dysfunction and sepsis-related morbidity and mortality.To identify the cardioprotective effects and precise cellular/m
Missense mutations in RyR2 underlie the condition CPVT, which is associated with cardiac arrhythmias during exercise or stress.CPVT mutations occur in 3 clusters, corresponding to the N-terminal, cent